GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,184 | -31.1% | 840 | 0.0% | 0.00% | – |
| Q2 2023 | $4,620 | +23000.0% | 840 | -81.9% | 0.00% | – |
| Q1 2023 | $20 | -89.1% | 4,650 | -90.0% | 0.00% | -100.0% |
| Q4 2022 | $184 | -99.9% | 46,700 | +29.0% | 0.00% | -50.0% |
| Q3 2022 | $191,000 | -23.9% | 36,200 | -5.2% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -1.6% | 38,200 | +10.1% | 0.00% | 0.0% |
| Q1 2022 | $255,000 | +5000.0% | 34,700 | +4237.5% | 0.00% | – |
| Q4 2021 | $5,000 | -94.7% | 800 | -78.9% | 0.00% | -100.0% |
| Q3 2021 | $95,000 | +331.8% | 3,800 | +375.0% | 0.00% | – |
| Q2 2021 | $22,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |